Chorus Limited
Chorus Limited (CHRYY) Financial Performance & Income Statement Overview
Explore the financials of Chorus Limited (CHRYY), including yearly and quarterly data on income, cash flow, and balance sheets.
Chorus Limited (CHRYY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Chorus Limited CHRYY financial performance.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $500.00M | $507.00M | $503.00M | $493.00M |
| Cost of Revenue | $340.00M | $183.00M | $336.00M | $337.00M |
| Gross Profit | $160.00M | $324.00M | $167.00M | $156.00M |
| Gross Profit Ratio | $0.32 | $0.64 | $0.33 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $49.00M | $17.00M | $43.00M | $47.00M |
| Operating Expenses | $49.00M | $17.00M | $48.00M | $50.00M |
| Total Costs & Expenses | -$389.00M | $200.00M | $384.00M | $387.00M |
| Interest Income | $1.00M | $6.00M | $2.00M | $3.00M |
| Interest Expense | $110.00M | $226.00M | $109.00M | $95.00M |
| Depreciation & Amortization | $235.00M | $185.00M | $228.00M | $224.00M |
| EBITDA | $347.00M | $309.00M | $349.00M | $333.00M |
| EBITDA Ratio | $0.69 | $0.61 | $0.69 | $0.67 |
| Operating Income | $111.00M | $307.00M | $119.00M | $106.00M |
| Operating Income Ratio | $0.22 | $0.61 | $0.24 | $0.22 |
| Other Income/Expenses (Net) | -$109.00M | -$298.00M | -$107.00M | -$92.00M |
| Income Before Tax | $2.00M | $9.00M | $12.00M | $14.00M |
| Income Before Tax Ratio | $0.004 | $0.02 | $0.02 | $0.03 |
| Income Tax Expense | $7.00M | $23.00M | $7.00M | -$2.00M |
| Net Income | -$5.00M | -$14.00M | $5.00M | $16.00M |
| Net Income Ratio | -$0.01 | -$0.03 | $0.010 | $0.03 |
| EPS | -$0.01 | -$0.03 | $0.01 | $0.04 |
| Diluted EPS | -$0.01 | -$0.02 | $0.01 | $0.02 |
| Weighted Avg Shares Outstanding | $433.89M | $536.48M | $433.89M | $435.33M |
| Weighted Avg Shares Outstanding (Diluted) | $559.00M | $620.00M | $433.89M | $644.42M |
Over the past four quarters, Chorus Limited demonstrated steady revenue growth, increasing from $493.00M in Q4 2023 to $500.00M in Q2 2025. Operating income reached $111.00M in Q2 2025, maintaining a consistent 22% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $347.00M, reflecting operational efficiency. Net income rose to -$5.00M, with EPS at -$0.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan